Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 26 , ISSUE 8 ( August, 2022 ) > List of Articles

SYSTEMATIC REVIEW

Role of Sedation and Analgesia during Noninvasive Ventilation: Systematic Review of Recent Evidence and Recommendations

Habib Md Reazaul Karim, Irena Šarc, Camilla Calandra, Savino Spadaro, Bushra Mina, Laura D Ciobanu, Gil Gonçalves, Vania Caldeira, Bruno Cabrita, Andreas Perren, Giuseppe Fiorentino, Tughan Utku, Edoardo Piervincenzi, Mohamad El-Khatib, Nilgün Alpay, Rodolfo Ferrari, Mohamed EA Abdelrahim, Haitham Saeed, Yasmin M Madney, Hadeer S Harb, Nicola Vargas, Hilmi Demirkiran, Pradipta Bhakta, Peter Papadakos, Manuel Á Gómez-Ríos, Alfredo Abad, Jaber S Alqahtani, Vijay Hadda, Subrata K Singha, Antonio M Esquinas

Keywords : Analgesia, Analgosedation, Discomfort, Noninvasive ventilation, Respiratory failure, Sedation, Sedoanalgesia

Citation Information : Karim HM, Šarc I, Calandra C, Spadaro S, Mina B, Ciobanu LD, Gonçalves G, Caldeira V, Cabrita B, Perren A, Fiorentino G, Utku T, Piervincenzi E, El-Khatib M, Alpay N, Ferrari R, Abdelrahim ME, Saeed H, Madney YM, Harb HS, Vargas N, Demirkiran H, Bhakta P, Papadakos P, Gómez-Ríos MÁ, Abad A, Alqahtani JS, Hadda V, Singha SK, Esquinas AM. Role of Sedation and Analgesia during Noninvasive Ventilation: Systematic Review of Recent Evidence and Recommendations. Indian J Crit Care Med 2022; 26 (8):938-948.

DOI: 10.5005/jp-journals-10071-23950

License: CC BY-NC 4.0

Published Online: 30-07-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

Aim: This systematic review aimed to investigate the drugs used and their potential effect on noninvasive ventilation (NIV). Background: NIV is used increasingly in acute respiratory failure (ARF). Sedation and analgesia are potentially beneficial in NIV, but they can have a deleterious impact. Proper guidelines to specifically address this issue and the recommendations for or against it are scarce in the literature. In the most recent guidelines published in 2017 by the European Respiratory Society/American Thoracic Society (ERS/ATS) relating to NIV use in patients having ARF, the well-defined recommendation on the selective use of sedation and analgesia is missing. Nevertheless, some national guidelines suggested using sedation for agitation. Methods: Electronic databases (PubMed/Medline, Google Scholar, and Cochrane library) from January 1999 to December 2019 were searched systematically for research articles related to sedation and analgosedation in NIV. A brief review of the existing literature related to sedation and analgesia was also done. Review results: Sixteen articles (five randomized trials) were analyzed. Other trials, guidelines, and reviews published over the last two decades were also discussed. The present review analysis suggests dexmedetomidine as the emerging sedative agent of choice based on the most recent trials because of better efficacy with an improved and predictable cardiorespiratory profile. Conclusion: Current evidence suggests that sedation has a potentially beneficial role in patients at risk of NIV failure due to interface intolerance, anxiety, and pain. However, more randomized controlled trials are needed to comment on this issue and formulate strong evidence-based recommendations. Abbreviations: ACPE, acute cardiogenic pulmonary edema; AECOPD, acute exacerbation of the chronic obstructive pulmonary disease; AHRF, acute hypercapnic respiratory failure; ALI/ARDS, acute lung injury/acute respiratory distress syndrome; ARF, acute respiratory failure; COPD, chronic obstructive pulmonary disease; EAdi, electrical activity of the diaphragm; ERS/ATS, European Respiratory Society/American Thoracic Society; ETI, endotracheal intubation; ICU, intensive care unit; IMV, invasive mechanical ventilation; LOS, length of stay; NAVA, neurally adjusted ventilatory assist; NIV, noninvasive ventilation; PSV, pressure support ventilation; PVD, patient-ventilator dyssynchrony; RCT, randomized controlled trial.


PDF Share
  1. Hillberg RE, Johnson DC. Noninvasive ventilation. N Engl J Med 1997;337(24):1746–1752. DOI: 10.1056/NEJM199712113372407.
  2. Mehta S, Hill NS. Noninvasive ventilation. Am J Respir Crit Care Med 2001;163(2):540–577. DOI: 10.1164/ajrccm.163.2.9906116.
  3. Rochwerg B, Brochard L, Elliott MW, Hess D, Hill NS, Nava S, et al. Official ERS/ATS clinical practise guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 2017;50(2):1602426. DOI: 10.1183/13993003.02426-2016.
  4. Jung JH, Lim YH, Lee JW, Choi WA, Suh MR, Kang SW. Remarkable improvement in a very severe chronic obstructive pulmonary disorder patient after use of noninvasive intermittent positive pressure ventilator: a case report. Medicine (Baltimore) 2018;97(43):e12877. DOI: 10.1097/MD.0000000000012877.
  5. Carlucci A, Richard JC, Wysocki M, Lepage E, Brochard L, SRLF Collaborative Group on Mechanical Ventilation. Noninvasive versus conventional mechanical ventilation. An epidemiologic survey. Am J Respir Crit Care Med 2001;163(4):874–880. DOI: 10.1164/ajrccm.163.4.2006027.
  6. Levy M, Tanios MA, Nelson D, Short K, Senechia A, Vespia J, et al. Outcomes of patients with do-not-intubate orders treated with noninvasive ventilation. Crit Care Med 2004;32(10):2002–2007. DOI: 10.1097/01.ccm.0000142729.07050.c9.
  7. Schettino G, Altobelli N, Kacmarek RM. Noninvasive positive pressure ventilation reverses acute respiratory failure in select “do-not-intubate” patients. Crit Care Med. 2005;33:1976–1982. DOI: 10.1097/01.ccm.0000178176.51024.82.
  8. Nava S, Hill N. Noninvasive ventilation in acute respiratory failure. Lancet 2009;374(9685):250–259. DOI: 10.1016/S0140-6736(09)60496-7.
  9. Shutes BL, Gee SW, Sargel CL, Fink KA, Tobias JD. Dexmedetomidine as single continuous sedative during noninvasive ventilation: typical usage, hemodynamic effects, and withdrawal. Pediatr Crit Care Med 2018;19:287–297. DOI: 10.1097/PCC.0000000000001451.
  10. Venkatraman R, Hungerford JL, Hall MW, Moore-Clingenpeel M, Tobias JD. Dexmedetomidine for sedation during noninvasive ventilation in pediatric patients. Pediatr Crit Care Med 2017;18(9):831–837. DOI: 10.1097/PCC.0000000000001226.
  11. Piastra M, Pizza A, Gaddi S, Luca E, Genovese O, Picconi E, et al. Dexmedetomidine is effective and safe during NIV in infants and young children with acute respiratory failure. BMC Pediatr 2018;18(1):282. DOI: 10.1186/s12887-018-1256-y.
  12. Ni YN, Wang T, Yu H, Liang BM, Liang ZA. The effect of sedation and/or analgesia as rescue treatment during noninvasive positive pressure ventilation in the patients with Interface intolerance after extubation. BMC Pulm Med 2017;17(1):125. DOI: 10.1186/s12890-017-0469-4.
  13. Deletombe B, Trouve-Buisson T, Godon A, Falcon D, Giorgis-Allemand L, Bouzat P, et al. Dexmedetomidine to facilitate noninvasive ventilation after blunt chest trauma: a randomised, double-blind, crossover, placebo-controlled pilot study. Anaesth Crit Care Pain Med 2019;38(5):477–483. DOI: 10.1016/j.accpm.2019.06.012.
  14. Longrois D, Conti G, Mantz J, Faltlhauser A, Aantaa R, Tonner P. Sedation in noninvasive ventilation: do we know what to do (and why)?. Multidiscip Respir Med 2014;9(1):56. DOI: 10.1186/2049-6958-9-56.
  15. Hilbert G, Navalesi P, Girault C. Is sedation safe and beneficial in patients receiving NIV? Yes. Intensive Care Med 2015;41(9):1688–1691. DOI: 10.1007/s00134-015-3935-6.
  16. Conti G, Hill NS, Nava S. Is sedation safe and beneficial in patients receiving NIV? No. Intensive Care Med 2015;41:1692. DOI: 10.1007/s00134-015-3915-x.
  17. Glossop AJ, Shephard N, Bryden DC, Mills GH. Noninvasive ventilation for weaning, avoiding reintubation after extubation and in the postoperative period: a meta-analysis. Br J Anaesth 2012;109(3):305–314. DOI: 10.1093/bja/aes270.
  18. Matsumoto T, Tomii K, Tachikawa R, Otsuka K, Nagata K, Otsuka K, et al. Role of sedation for agitated patients undergoing noninvasive ventilation: clinical practice in a tertiary referral hospital. BMC Pulm Med 2015;15:71. DOI: 10.1186/s12890-015-0072-5.
  19. Muriel A, Peñuelas O, Frutos-Vivar F, Arroliga AC, Abraira V, Thille AW, et al. Impact of sedation and analgesia during noninvasive positive pressure ventilation on outcome: a marginal structural model causal analysis. Intensive Care Med 2015;41(9):1586–1600. DOI: 10.1007/s00134-015-3854-6.
  20. Devlin JW, Nava S, Fong JJ, Bahhady I, Hill NS. Survey of sedation practices during noninvasive positive-pressure ventilation to treat acute respiratory failure. Crit Care Med 2007;35(10):2298–2302. DOI: 10.1097/01.CCM.0000284512.21942.F8.
  21. Vaschetto R, Cammarota G, Colombo D, Longhini F, Grossi F, Giovanniello A, et al. Effects of propofol on patient-ventilator synchrony and interaction during pressure support ventilation and neurally adjusted ventilatory assist. Crit Care Med 2014;42(1):74–82. DOI: 10.1097/CCM.0b013e31829e53dc.
  22. Cavaliere F, Antonelli M, Arcangeli A, Conti G, Costa R, Pennisi MA, et al. A low-dose remifentanil infusion is well tolerated for sedation in mechanically ventilated, critically ill patients. Can J Anaesth 2002;49(10):1088–1094. DOI: 10.1007/BF03017909.
  23. Conti G, Arcangeli A, Antonelli M, Cavaliere F, Costa R, Simeoni F, et al. Sedation with sufentanil in patients receiving pressure support ventilation has no effects on respiration: a pilot study. Can J Anaesth 2004;51(5):494–499. DOI: 10.1007/BF03018315.
  24. Costa R, Navalesi P, Cammarota G, Longhini F, Spinazzola G, Cipriani F, et al. Remifentanil effects on respiratory drive and timing during pressure support ventilation and neurally adjusted ventilatory assist. Respir Physiol Neurobiol 2017;244:10–16. DOI: 10.1016/j.resp.2017.06.007.
  25. Gifford AH, Mahler DA, Waterman LA, Ward J, Kraemer WJ, Kupchak BR, et al. Neuromodulatory effect of endogenous opioids on the intensity and unpleasantness of breathlessness during resistive load breathing in COPD. COPD 2011;8(3):160–166. DOI: 10.3109/15412555.2011.560132.
  26. Peiffer C. Morphine-induced relief of dyspnea: what are the mechanisms? Am J Respir Crit Care Med 2011;184(8):867–869. DOI: 10.1164/rccm.201108-1463ED.
  27. Davidson C, Banham S, Elliott M, Kennedy D, Gelder C, Glossop A, et al. British Thoracic Society/Intensive Care Society Guideline for the ventilatory management of acute hypercapnic respiratory failure in adults. BMJ Open Respir Res 2016;3(1):e000133. DOI: 10.1136/bmjresp-2016-000133.
  28. Sengoku N, Oksuz H, Dogan Z, Yildiz H, Demirkiran H, Ekerbicer H. Sedation during noninvasive mechanical ventilation with dexmedetomidine or midazolam: a randomised, double-blind, prospective study. Curr Ther Res 2010;71:141–153. DOI: 10.1016/j.curtheres.2010.06.003.
  29. Allam MG. Dexmedetomidine versus midazolam for sedation of critically ill patients on noninvasive mechanical ventilation. Ain-Shams J Anaesthesiol 2016;9(2):178–185. DOI: 10.4103/1687-7934.179910.
  30. Huang Z, Chen YS, Yang ZL, Liu JY. Dexmedetomidine versus midazolam for the sedation of patients with noninvasive ventilation failure. Intern Med 2012;51(17):2299–2305. DOI: 10.2169/internalmedicine.51.7810.
  31. Devlin JW, Al-Qadheeb NS, Chi A, Roberts RJ, Qawi I, Garpestad E, et al. Efficacy and safety of early dexmedetomidine during noninvasive ventilation for patients with acute respiratory failure: a randomised, double-blind, placebo-controlled pilot study. Chest 2014;145(6):1204–1212. DOI: 10.1378/chest.13-1448.
  32. Morel DR, Forster A, Gemperle M. Noninvasive evaluation of breathing pattern and thoraco-abdominal motion following the infusion of Ketamine or droperidol in humans. Anesthesiology 1986;65(4):392–398. DOI: 10.1097/00000542-198610000-00008.
  33. Miller AC, Jamin CT, Elamin EM. Continuous intravenous infusion of ketamine for maintenance sedation. Minerva Anestesiol 2011;77:812–820.
  34. Parashchanka A, Schelfout S, Coppens M. Role of novel drugs in sedation outside the operating room: dexmedetomidine, ketamine and remifentanil. Curr Opin Anaesthesiol 2014;27(4):442–447. DOI: 10.1097/ACO.0000000000000086.
  35. Shurtleff V, Radosevich JJ, Patanwala AE. Comparison of ketamine-versus nonketamine-based sedation on delirium and coma in the intensive care unit. J Intensive Care Med 2020;35(6):536–541. DOI: 10.1177/0885066618767619.
  36. Garber PM, Droege CA, Carter KE, Harger NJ, Mueller EW. Continuous infusion ketamine for adjunctive analgosedation in mechanically ventilated, critically ill patients. Pharmacotherapy 2019;39(3):288–296. DOI: 10.1002/phar.2223.
  37. Scala R. Sedation during noninvasive ventilation to treat acute respiratory failure. Shortness Breath 2013;2:35–43. (No doi). Manuscript available from: http://eprints.bice.rm.cnr.it/8294/1/article_(5).pdf.
  38. Talsi O, Kiiski Berggren R, Johansson G, Winsö O. A national survey on routines regarding sedation in Swedish intensive care units. Ups J Med Sci 2019;124(3):199–202. DOI: 10.1080/03009734.2019.161 6339.
  39. Jakob SM, Ruokonen E, Grounds RM, Sarapohja T, Garratt C, Pocock SJ, et al. Dexmedetomidine vs. midazolam or propofol for sedation during prolonged mechanical ventilation: two randomised controlled trials. JAMA 2012;307:1151–1159. DOI: 10.1001/jama.2012.304.
  40. Strom T, Martinussen T, Toft P. A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet 2010;375(9713):475–480. DOI: 10.1016/S0140-6736(09) 62072-9.
  41. Devlin JW, Skrobik Y, Gélinas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med 2018;46(9):e825–e873. DOI: 10.1097/CCM.0000 000000003299.
  42. Chawla R, Dixit SB, Zirpe KG, Chaudhry D, Khilnani GC, Mehta Y, et al. ISCCM guidelines for the use of noninvasive ventilation in acute respiratory failure in adult ICUs. Indian J Crit Care Med 2020;24 (Suppl. 1):S61–S81. DOI: 10.5005/jp-journals-10071-G23186.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.